# Safety and Efficacy of Magnesium Sulphate as an Adjuvant to Levobupivacaine in Ultra-sound Guided Transversus Abdominis Plan Block in Pediatric Abdominal Cancer Surgery

> **NCT03979599** · PHASE3 · UNKNOWN · sponsor: **South Egypt Cancer Institute** · enrollment: 10 (estimated)

## Conditions studied

- Postoperative Pain

## Interventions

- **PROCEDURE:** ultra-sound guided transversus abdominis plan block
- **DRUG:** magnesium sulphate& levobupivacaine
- **DRUG:** Levobupivacaine

## Key facts

- **NCT ID:** NCT03979599
- **Lead sponsor:** South Egypt Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-15
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-06-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03979599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03979599, "Safety and Efficacy of Magnesium Sulphate as an Adjuvant to Levobupivacaine in Ultra-sound Guided Transversus Abdominis Plan Block in Pediatric Abdominal Cancer Surgery". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03979599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*